Softwr

Research · head to head

Genedata vs Zappi

Genedata logo

Genedata

Research

Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher

From
On request
Rated
-
Full reviewWebsite
Zappi logo

Zappi

Research

Automated consumer insights platform for testing advertising, product concepts and brand health

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Genedata there is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.; Zappi nothing is published: pricing is a platform subscription plus a prepaid credit bundle quoted per customer, so a buyer cannot benchmark the cost against agency research without going through sales.
  • They diverge on capability: Genedata covers Screener, Zappi covers Validated study templates.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Genedata and Zappi actually diverge.

Attributes where Genedata and Zappi differ
AttributeGenedataZappi
PlatformsWeb, On-premise, Private cloudWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Genedata

  • Screener
  • Biologics
  • Bioprocess
  • Expressionist
  • Selector
  • Profiler
  • Instrument integration
  • GxP-capable deployments

Only in Zappi

  • Validated study templates
  • Respondent panel access
  • Normative benchmarks
  • Creative testing
  • Brand health tracking
  • AI analysis over history
  • Unlimited users
  • Exports and integrations

What people use each for

The jobs each tool is most often brought in to do.

Genedata

  • A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot Zappi
  • A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot Zappi
  • A process development group standardising bioprocess run data across sites for modelling and scale-upnot Zappi
  • A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot Zappi

Zappi

  • A beverage brand screening thirty flavour concepts before committing to two for consumer testingnot Genedata
  • A marketing team pre-testing three advertising edits in a day so a media booking deadline can be metnot Genedata
  • An insights function replacing repeated ad-hoc agency studies with a comparable, accumulating body of test resultsnot Genedata
  • A brand manager running continuous brand health tracking without negotiating a separate tracker contract each yearnot Genedata

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Genedata

  • There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them.
  • Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice.
  • Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors.
  • Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case.

Zappi

  • Nothing is published: pricing is a platform subscription plus a prepaid credit bundle quoted per customer, so a buyer cannot benchmark the cost against agency research without going through sales.
  • Credits are prepaid against a forecast of the year ahead, which means a team that overestimates research volume ends the year having paid for studies it never ran.
  • The template model that makes studies fast also constrains them; a research question that does not fit a validated instrument either gets forced into one or goes to an agency anyway.
  • Normative benchmarks are strongest in fast-moving consumer goods categories where Zappi has depth, and thinner in business-to-business, financial services and niche categories, where the comparison numbers mean less.
  • Because respondents come from Zappi-sourced panels, sample composition is a vendor decision rather than yours, and any team that needs a bespoke recruitment specification or a low-incidence audience will find the automated route unsuitable.

Pricing, plan by plan

Genedata

On request
  • Genedata platform licence$undefined/year
    • Each platform, such as Screener or Biologics, licensed separately
    • Annual enterprise subscription scoped on users, sites and data volume
    • Implementation and scientific configuration services quoted as a separate programme

Zappi

On request
  • Premium$undefined/year
    • Platform subscription with unlimited users
    • Access to all research solutions
    • Credit bundle scoped to annual research volume
  • Enterprise$undefined/year
    • Platform subscription with unlimited users
    • Multi-market and global organisation controls
    • Connected insights across markets and brands

Which should you pick?

Choose Genedata if

  • You need screener.
  • You work on Web, On-premise, Private cloud.
  • You also want biologics.
Genedata review

Choose Zappi if

  • You need validated study templates.
  • You also want respondent panel access.
Zappi review

Questions people ask

Is Genedata or Zappi better?
Neither clearly leads. Genedata starts at On request and Zappi at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Genedata or Zappi?
Genedata starts at On request and Zappi at On request.
Does Genedata or Zappi run on more platforms?
Genedata runs on Web, On-premise, Private cloud. Zappi runs on Web.
What is Genedata best used for?
Genedata is most often used for a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale, a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets, a process development group standardising bioprocess run data across sites for modelling and scale-up, a cro delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelines. Of those, a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale and a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets are not what Zappi is typically brought in for.
What can Genedata do that Zappi cannot?
Genedata covers Screener, Biologics, Bioprocess, Expressionist. Zappi covers Validated study templates, Respondent panel access, Normative benchmarks, Creative testing.

Answered from the vendors’ own pages

Genedata: Who owns Genedata?

Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.

Zappi: Does Zappi publish prices?

No. It publishes the structure, a platform subscription plus credits plus optional services, but not the numbers.

Genedata: Is there a small-team or starter option?

No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.

Zappi: How fast do results come back?

Automated tests typically return within hours to a day, which is the main reason teams choose it over a commissioned study.

Genedata: Do I buy one product or the whole suite?

Each platform is licensed separately. Most customers license two or three and integrate between them.

Zappi: Do we still need an agency?

For standard concept, creative and brand tests, usually not. For bespoke methodologies and hard-to-reach audiences, yes.

Genedata: Can it be used in a GxP environment?

Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.

Zappi: Is there a per-seat charge?

No. Both published tiers include unlimited users; the variable cost is research credits.

Share

Related pages

More on Genedata

More on Zappi

Keep looking

Other head to heads